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Aims: To develop and evaluate a feasible, authentic pharmacist‐led prescribing
feedback intervention for doctors‐in‐training, to reduce prescribing errors.
Methods: This was a mixed methods study. Sixteen postgraduate doctors‐in train-
ing, rotating though the surgical assessment unit of 1 UK hospital, were filmed taking
a medication history with a patient and prescribing medications. Each doctor
reviewed their video footage and made plans to improve their prescribing, supported
by feedback from a pharmacist. Quantitative data in the form of prescribing error
prevalence data were collected on 1 day per week before, during and after the inter-
vention period (between November 2015 and March 2017). Qualitative data in the
form of individual semi‐structured interviews were collected with a subset of partic-
ipants, to evaluate their experience. Quantitative data were analysed using a statisti-
cal process chart and qualitative data were transcribed and analysed thematically.
Results: During the data collection period, 923 patient drug charts were reviewed
by pharmacists who identified 1219 prescribing errors overall. Implementation of this
feedback approach was associated with a statistically significant reduction in the
mean number of prescribing errors, from 19.0/d to 11.7/d (estimated to equate to
38% reduction; P < .0001). Pharmacist‐led video‐stimulated prescribing feedback
was feasible and positively received by participants, who appreciated the reinforce-
ment of good practice as well as the opportunity to reflect on and improve practice.
Conclusions: Feedback to doctors‐in‐training tends to be infrequent and often neg-
ative, but this feasible feedback strategy significantly reduced prescribing errors and
was well received by the target audience as a supportive developmental approach.
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1 | INTRODUCTION
Prescribing errors are common in healthcare settings. Defining what
counts as a prescribing error is challenging but generally includes
transcription errors, failures to communicate essential information,
and the use of drugs or doses inappropriate for the individual patient.1
Different studies report different levels of prescribing error (e.g.2,3),
reflecting true variations and differences in definitions and study
designs. For example, in Ashcroft et al.’s study,2 the mean error rate
was 8.8 errors per 100 medication orders; and in Seden et al.’s study,3
1 or more error was observed in 43.8% of prescriptions. Despite the
interpretation challenges,4 such figures are alarmingly high and it is
clear that a subset of these errors pose a real threat to patient safety.
Doctors‐in‐training are an important group to support in developing
their prescribing capabilities. They are reported to be underprepared
for their prescribing responsibilities upon graduation5 and yet shoulder
a large proportion of the prescribing activities within hospitals in UK
settings and beyond.2 Therefore if prescribing amongst doctors‐in‐
training could be improved, there is significant potential to reduce
prescribing errors and improve patient safety.
Unfortunately, prescribing practices are hard to change. Although
usually attributed to an individual prescriber, it is increasingly clear
that prescribing errors are typically multifactorial, involving multiple
people working in a complex, interrelated and fast‐moving healthcare
systems.6-9 This means that solutions that focus on a single cause,
such as a knowledge deficit, are likely to lead to limited benefits.7,10,11
The social elements of healthcare team working are increasingly
recognised as important in relation to prescribing errors.8,12-15 Thus,
doctors‐in‐training need to learn how to liaise productively and
sensitively within a team that includes a range of healthcare profes-
sionals of different grades, in order to achieve the best outcomes for
patients.16 The medical hierarchy has been identified as a particular
challenge for junior professionals to overcome, with medical trainees
often reluctant to question senior colleagues.6,8
Feedback is an intervention with substantial promise to improve
the prescribing capabilities of doctors‐in‐training, having already been
demonstrated to make a significant positive impact on other important
educational and healthcare outcomes.17-20 Feedback can allow activi-
ties in real practice settings to be reviewed in a holistic way by
experts, which can promote meaningful behaviour change. Although
professional bodies state that doctors‐in‐training should be provided
with regular feedback on their prescribing practices in a structured
and supportive way,21 in practice doctors‐in‐training report infrequent
and/or suboptimal feedback, for various reasons.15 Feedback appears
to be most effective in healthcare settings when the recipient has a
low baseline performance (as might be expected with doctors‐in‐
training), when it is given by a supervisor or colleague, when it is given
more than once, and both verbally and written, and when it results in
an action plan.17 In relation to prescribing errors specifically, feedback
appears most effective for learning when it is timely, and provides
a comprehensive, contextualised benchmark from which the pre-
scriber can compare their prescribing behaviours and current level of
knowledge.22
Having identified feedback to doctors‐in‐training as a useful inter-
vention type, it is also increasingly apparent that pharmacists are well
placed to help. Pharmacists are established members of the clinical
team with expertise that is relevant to the prescribing of medications.
Importantly, they sit outside the medical hierarchy, and have been
suggested as well placed to support and develop the prescribing prac-
tices of doctors‐in‐training (e.g.9,15). Recent research from Australia
highlighted significant potential for co‐working between doctors‐in‐
training and pharmacists to develop effective prescribing practices,
for example through pharmacists developing roles in learning facilita-
tion rather than error identification.16 McLellan et al. demonstrated
that a structured feedback session for doctors‐in‐training facilitated
by pharmacists based on real patient cases increased rates of appro-
priate antimicrobial prescribing.9 Importantly, Noble et al.23 advocated
greater emphasis on interprofessional collaboration for learning in
everyday activities and interactions, rather than more traditional
approaches to education which often occur beyond the everyday
work setting. Therefore, we developed a model of pharmacist‐led
feedback for doctors‐in‐training that was embedded within their work
environment and aligned to their everyday prescribing tasks.
2 | METHODS
2.1 | Aim
To develop and evaluate a feasible, authentic pharmacist‐led
prescribing feedback intervention for doctors‐in‐training, to reduce
prescribing errors.
What is already known about this subject
• Feedback can be an impactful educational intervention.
• Doctors‐in‐training represent the largest group of
hospital prescribers but rarely receive feedback on
prescribing.
• Pharmacists, as medication experts and established
members of clinical teams, are well placed to support
the development of good prescribing in doctors‐in‐
training.
What this study adds
• Implementing a well‐designed feedback intervention can
reduce prescribing errors substantially (we estimate by
38% in our study; P < .0001).
• Supportive feedback may be positively received by
doctors‐in‐training as a means to improve their practice.
• Such interventions need not be expensive, with time
investment in giving feedback balanced by the errors
prevented.
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2.2 | Project design
This mixed‐methods study, with a convergent design, combined quan-
titative data in the form of prescribing error prevalence data measured
each week before, during and after the intervention period; and qual-
itative data in the form of semi‐structured interviews with a subset of
participants who took part in the project. To maximise the likelihood
of success, the feedback intervention was co‐designed by the authors
(3 pharmacists, a consultant surgeon and a professor of medical edu-
cation) and other key stakeholders (including pharmacists, patient rep-
resentatives, a doctor‐in‐training and a consultant microbiologist),
incorporating knowledge from the published literature. For example,
given the knowledge mobilisation literature that highlights the chal-
lenges of transferring learning to practice,24 we provided feedback in
real clinical settings in relation to real patients that the doctor‐in‐
training had seen. The principles underpinning the design were to:
maximise authenticity by embracing the complexity of practice; maxi-
mise timeliness and relevance of feedback for participants; and mini-
mise cost to ensure feasibility. The feedback approach was refined
through iterative rounds of piloting, incorporating feedback from a
variety of healthcare professionals from a range of settings.
2.3 | Participants and setting
Participants were doctors‐in‐training, 1–4 years postgraduation, rotat-
ing through the Surgical Assessment Unit (SAU) at a National Health
Service teaching hospital in Southwest England. The SAU was selected
because a large proportion of doctors‐in‐training rotate through this
setting; they tend to work more autonomously as surgeons are often
not physically present on the ward; and there was good buy‐in for the
project from senior clinicians in that setting for our project. Recruitment
was led by a middle‐grade pharmacist (O.F.), who was already known to
the participants since he was the pharmacist allocated to that ward,
from November 2016 to February 2017. All potential participants were
provided with written and verbal information about the project. Subse-
quently, participants were asked to sign a consent form if they wished
to participate, with assurances that there would be no negative impact
on their reputation or access to training if they declined. Patients also
gave their written consent to be involved. The project was deemed
quality improvement by the trust Clinical Research Advisor, and there-
fore did not require formal ethical approval. It was discussed and
approved via the appropriateTrust governance groups.
2.4 | Approach to filming
A pharmacist (O.F.) identified potentially suitable patients during their
routine clinical practice and explained the purpose of the project.
Patients were eligible to be involved in the study if they were on 4
or more medications; were clinically stable and not confused; and
were willing to participate. Once a suitable patient was available, the
pharmacist introduced the doctor participant to the patient; gave a
brief summary of the patient's presenting complaint; set up the cam-
era with the image trained on the doctor‐in‐training; and asked the
doctor to complete a medication history and prescribe appropriate
medication for the patient including any necessary antibiotics (in the
same way they would in a normal clinical encounter). Doctor partici-
pants were provided with a drug chart and a medications reconcilia-
tion clerking proforma which forms part of the routine clerking
paperwork. Where prescribing happened remotely from the patient
consultation, this was also recorded. Doctors typically relocated to
the nurses' station to complete patient drug charts.
2.5 | Feedback sessions
Feedback sessions occurred within 3 days of filming, at a mutually
agreeable time and location for the doctor participant and pharmacist.
Prior to the feedback session, the pharmacist watched the video
footage (typically 15–20 minutes); checked the patient's medication
history; and reviewed the clinical information and drug chart. Feedback
sessions typically lasted 30–45 minutes and took place in a meeting
room. The pharmacist reiterated the project's aims and the
consultation/prescribing footagewas reviewed together and discussed.
The feedback processwas supported by a purpose‐made feedback con-
versation schedule (see Supplementary Information), underpinned by
Self‐Regulated Learning theory.25,26 Self‐regulated learning involves
metacognition (thinking about one's own thinking), strategic action
(planning and evaluating activity against a standard), and motivation
for learning. This theory was selected for this study due to its ability
to empower participants to evaluate their clinical practice and learning
needs. At the end of each session, the doctor and pharmacist developed
and agreed an improvement plan.
2.6 | Prescribing error data (quantitative)
A pharmacist (O.F.) collected prescribing error data once a week, on
the post‐take surgical ward round and during routine practice/ward
work on the SAU. The data collected included: the number of patients
seen; number of patients with a venous thromboembolism risk
assessment completed and prophylaxis appropriately prescribed;
number of patients on antimicrobials and whether these prescriptions
were compliant with local prescribing guidelines (i.e. were appropri-
ately documented and compliant with local guidelines or targeted to
sensitivities); number of patients with correctly documented allergy
status; and the number of pharmacist interventions made. For the
purposes of this study, each pharmacist intervention was considered
to equate to a prescribing error: this included use of drugs or doses
inappropriate for the individual patient, transcription errors, ceasing
of antibiotic prescriptions that are no longer required and failures to
communicate essential information (e.g. venous thromboembolism
assessment, antimicrobial indications or review/stop dates, correct
patient allergy status). The approach to measurement was exactly
the same in the baseline, test and sustain phases and so the data
are directly comparable, but data on error severity were only available
after the feedback intervention was introduced. Where a prescribing
error meeting the definition provided by the EQUIP study27 was
identified, a detailed description of the error was documented. This
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included: details of prescribing error; the medication involved; the
prescriber's grade; and the risk of harm posed by the prescribing error
using the severity error classification scheme from the EQUIP
study.27 Prescribing error data were then collated in a Microsoft
Excel spreadsheet and analysed using a statistical analysis program
for statistical process control charts (the Life System: https://uk.
lifeqisystem.com/). An I‐chart was used and statistical significance
was tested using Nelson's rules.28
2.7 | Semistructured interview data (qualitative)
A subset of the doctor participants (n = 6) attended a semistructured
interview, which aimed to gain an understanding of the participant's
experiences of the feedback intervention. Given the richness of the
data, this number was sufficient to meet the aim of providing further
insights into the feedback process. The 6 doctors were purposively
selected to maximise variation by O.F. and K.M., based on their demo-
graphic data (e.g. sex, stage of training) and/or the nature of their
feedback intervention (e.g. patient characteristics, nature of the feed-
back), to ensure representation of a wide range of feedback interven-
tion experiences. Interviews were conducted by a Professor of
Medical Education (K.M.) who was not involved in participant recruit-
ment or the feedback session, to encourage participants to speak
freely about their experience of the feedback intervention. The doc-
tors were asked to describe their experience of being involved in the
feedback intervention, from start to finish, with questions from the
interviewer prompting a more in‐depth account where necessary.
Each interview typically lasted 25 minutes and was conducted at a
mutually convenient time and location. Interviews were audio‐
recorded, transcribed verbatim and analysed using an inductive the-
matic analysis approach to identify key concepts and topics.
3 | RESULTS
3.1 | Participants
Sixteen (9 male, 7 female) of the 25 doctors‐in‐training, rotating
through the SAU and given the opportunity to participate, completed
the intervention. They had an age range of 23–31 years and had all
had been working as a doctor for <4 years.
3.2 | Prescribing errors
Prior to the study, the pharmacist reviewed 682 patients over 50 days
leading to 950 pharmacy interventions (each relating to 1 prescribing
error). During the implementation phase, 241 patients were reviewed
over 23 days leading to 269 interventions. Pharmacist interventions
postintervention included correction of serious prescribing errors; ces-
sation of inappropriate prescriptions e.g. antimicrobials; dosage alter-
ations to account for renal/liver function; allergy status corrections;
alteration to the route of administration; the addition of overlooked
regular medication; and requests for the completion of venous
thromboembolism risk assessments and prescribing of appropriate
prophylaxis. Implementation of the prescribing feedback initiative led
to a significant reduction in prescribing errors (Figure 1). The mean
number of prescribing errors reduced from 19.0/d to 11.7/d
representing an estimated 38% decrease overall (P < .0001) and 20%
less errors per patient (Table 1). The statistical process chart demon-
strated that this was a statistically significant change with a false neg-
ative rate of <6.5%.29 Interpretation of this decrease makes the
assumption that the number of patients (and therefore average num-
ber of prescriptions written) was stable throughout the evaluation
period but the weekly patient admissions data for the Surgical Admis-
sions Unit over the same period show a backdrop of increasing patient
numbers, rising from 51.0 during the baseline period, to 62.8 during
the test period and 69.1 during the sustain period (Figure 2). This
means that the estimated 38% error reduction may be understating
the true benefits of the intervention. While the majority of the 269
prescribing errors posed little risk of harm to the affected patients,
we were able to identify errors at all levels of severity according to
the severity of error classification scheme used by the EQUIP study,
including some that were potentially fatal and some that posed a
significant risk of harm (see Table 2). The prescribing errors
predominantly related to regular medicines (medicines the patient
was taking when admitted to hospital) rather than those initiated on
admission, although this might simply reflect the relative proportions.
3.3 | Participant experiences
The themes arising from the analysis including acceptability, authentic-
ity, experience of filming and feedback, and commitment to behaviour
change (Table 3). Participants commented on the acceptability of the
intervention, particularly their experience of being videoed on the
ward. In general, although they were conscious of it, being videoed
did not pose a barrier to participation for doctors‐in‐training or patients
(Table 3, topic 3.1). Some participants felt that this awareness meant
that they were more thorough in their history taking than usual
(Table 3, topic 3.1), although others said that it did not affect the way
they worked. Patients appeared happy to be involved in the project.
This may partly be due to the fact that manywerewaiting for scans, test
results, operations or to be discharged, and so it offered a way of pass-
ing the time. Doctor participants also commented on the authenticity of
the task they were asked to complete (Table 3, topic 3.2). Many
reported that the brief they were given, to take a medication history
from a patient and write up a drug chart, was a very typical activity. Par-
ticipants were overwhelmingly positive about the experience of receiv-
ing feedback on their prescribing practice (Table 3, topic 3.3) and about
pharmacists providing this feedback, perceiving them as highly knowl-
edgeable about medications and the prescribing process (Table 3, topic
3.4). Participants described the kinds of characteristics of the person
giving feedback that they felt underpinned a positive feedback conver-
sation, which included being relaxed, nonjudgemental and supportive in
their approach (Table 3, topic 3.5). Participants reported that reviewing
the video as part of the feedback session had been very beneficial and
provided novel insights (Table 3, topic 3.6). The video provided insights
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into social complexity that drug chart review alone could not
achieve and highlighted the degree of interruptions inherent in their
clinical practice. Most participants noted the busy environment in
which they wrote up the drug chart, and how often they were
interrupted, which was evident from the film footage (see Table 3,
quote 3.6.1). Some also reflected on their communication skills when
taking a history with the patient. Many participants reported that they
already had, or intended to, change their behaviour as a result of the
intervention (Table 3, topic 3.7).
4 | DISCUSSION
The aim of this project was to develop and evaluate a feasible, authen-
tic prescribing feedback intervention, facilitated by a pharmacist, for
doctors‐in‐training to reduce prescribing errors. To date, there has
been limited research focusing on providing structured prescribing
feedback for doctors‐in‐training in a way that is close to everyday
practice.23 We demonstrated that the video‐stimulated feedback ini-
tiative for doctors‐in‐training was associated temporally with a statis-
tically significant reduction in pharmacist interventions, each equating
to a prescribing error.
Participants felt that the design features built into the intervention
(e.g. authentic task, authentic environment, feedback on prescribing,
feedback by pharmacist) had enabled them to identify errors, reflect
on them and commit to behaviour change to avoid them. Although
they tended to be aware of the camera, this did not appear to detract
from the beneficial effects of the exercise. One common observation
by participants on reviewing the film footage was the busy, distracting
locations chosen by doctors‐in‐training to prescribe medicines and
complete documentation. The vast majority of doctor participants
used the nurses' station, in the middle of the surgical admissions unit,
to sit or stand at and complete documentation or drug charts, and this
is common practice on hospital wards in many UK hospitals. However,
this location is fraught with inherent distractions and human factors,
FIGURE 1 Statistical process chart showing pharmacist interventions per day (each equating to a prescribing error) over 18 months on the surgical
admissions unit. The dates are given on the X‐axis. The test phase is shaded white and is when the initial pulse of the intervention was carried out.
The baseline data, to the left of this, was collected before the project. The sustain phase, to the right of this, is when the remainder of the participants
took part in the intervention. The horizontal lines in the baseline and sustain phases show themean, with lines above and below this representing 1, 2
and 3 sigma from the mean. The 3 sigma from the mean lines are also called the upper and lower control limits. These statistics show that the mean
has significantly reduced in the sustain phase and the variance (sigma) has also reduced, since the lines are closer together
TABLE 1 Data showing the changes in pharmacist intervention rates
and therefore prescribing errors, each reflected by a pharmacist
intervention, at baseline and after the feedback intervention
Baseline (over
50 days)
Project (over
23 days)
Percentage
reduction
Number of patients 682 241 ‐
Number of pharmacist
interventions
950 269 ‐
Average pharmacist
interventions per day
19.0 11.7 38%
Average pharmacist
interventions
per patient
1.39 1.12 20%
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including diverse clinical staff, patients and carers, phones, radios, and
alarms. As a result of our project, some participants reported trying to
utilise an office space as a result of watching back the video footage,
away from the distractions and interruptions of the nurse's station.
Anecdotally, the use of this office by doctors‐in‐training increased
over the project timeline and has continued since as practice
handed‐on to new doctors‐in‐training rotating into this setting.
Previous research has highlighted the high frequency of workflow
interruptions in hospital settings for a range of professionals, particu-
larly in settings such as the intensive care unit and emergency
TABLE 2 Examples of errors in the 4 different categories that were discovered and corrected during the project
Potentially fatal
• 83‐year‐old woman incorrectly prescribed 80 mg of bisoprolol (a relatively potent β‐blocker) once a day by an FY1 doctor. This should have been
propranolol (a less potent β‐blocker). This was spotted and corrected by a pharmacist before it could be given to the patient. Giving such a high dose
of bisoprolol would have resulted in profound bradycardia (slow pulse) with hypotension (low blood pressure) and could have led to serious cardiac
conduction abnormalities, potential cardiac arrest and death.
Serious
• 67‐year‐old man incorrectly prescribed Morphgesic (prolonged release morphine) 180 mg twice a day. This was spotted and corrected by a
pharmacist before it could be given to the patient. Inappropriately high doses of opioids can lead to bradycardia, respiratory depression and
hypotension requiring administration of an antidote.
Significant
• 94‐year‐old man, with a history of atrial fibrillation, was prescribed apixaban 2.5 mg once a day. This should have been twice a day as per his drug
history. This was corrected by the pharmacist.
Minor
• 74‐year‐old man prescribed ondansetron 4–8 mg oral or intravenously when required as an antiemetic. However, no frequency or minimum dosing
interval was specified. This was corrected by the pharmacist.
FIGURE 2 Weekly patient admissions data for the surgical admissions unit over the same time period as the statistical process chart in Figure 1,
demonstrating an overall increasing trend (mean weekly admissions is 51.0 during the baseline period, 62.8 during the test period and 69.1 during
the sustain period)
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ward.30,31 One ward‐based observation study suggested that paedia-
tricians were disrupted 4.7 times on average per hour, by medical
colleagues (30.2%), nursing staff (29.7%) and telephone/beeper calls
(16.3%), leading to recommendations concerning work re‐design.32 In
a retrospective review of patient safety event reports involving
interruptions of clinical activities, medication tasks were mentioned
most frequently (50.9%), with the most common medication error
being wrong dose administration (14.4% of total medication‐related
errors).31 A recent review of interruptions in the context of nursing
medication administration in hospital settings concluded that
interruptions are likely to occur at least once during nursing medica-
tion administration processes in hospital settings.33 These authors
recommended that individuals and organisations adopt interruption
management strategies to decrease prescribing errors and increase
task efficiency.
The most important impact of the feedback intervention is the
reduction in prescribing errors that can lead to significant patient harm
but there were other benefits too. Providing feedback to doctors‐in‐
training in a supportive way (as in this study) can help them to feel
valued in the workplace, and confident in their trajectory towards
the next stage of medical training. This is important in light of alarming
reports of mental ill‐health in doctors‐in‐training—and lower propor-
tions of doctors continuing directly into the next stage of training 2
years after graduation in the UK.34
TABLE 3 Excerpts from semistructured interviews with doctors‐in‐training. Each participant had a unique code. The first part of the code
denotes their grade and the last part denotes their sex. Thus, the code “F1A‐F" reflects a foundation year 1 (F1) participant who is female
Topic Exemplar quotes
3.1. Acceptability of intervention 3.1.1 “I wasn't really bothered [about the video] … I probably did a much more thorough job because I knew I was
being videoed … but it didn't really bother me.” F1B‐M.
3.1.2 “She [the patient] didn't mind that I was being filmed at all.” F1B‐F.
3.2. Authenticity of intervention 3.2.1 “I'd rather have known the patient and known what they're in with, but actually it's the same as in clinical
practice, we often have to just take a drug history isolated from anything else.” F1A‐M.
3.2.2 “So like taking isolated drug history felt a little bit more forced, because … you can normally put medications
into context, so like I'll know a bit more about their medical background, so you can think about why they might
be taking these ones, whereas taking it in isolation is difficult … a bit more challenging maybe … more artificial.”
F1A‐F.
3.3. Experience of feedback 3.3.1 “It was really useful actually [the feedback session]... we don't often get a huge amount of feedback as F1 s.”
F1B‐F.
3.3.2 “Although you get lots of interaction with pharmacists on the wards, them picking up different drugs you
prescribe, it's sort of nice to hear positive feedback as well, it's like reinforcement of what you are doing right.”
F1A‐F.
3.3.3 “I've never had that area of my clerking reviewed scrutinised or supervised in any way.” CT1A‐M.
3.4. Receiving feedback from
pharmacists
3.4.1 “I've obviously been involved with quite few pharmacists on the ward … their knowledge base is far, far
superior to what I probably will ever have … they are all very nice as well.” F1B‐M.
3.4.2 “Particularly when it comes to prescribing, they're [pharmacists are] the first line people who I ask for advice,
so it makes sense that they are the ones who feedback. And they are the ones who check our drug charts, you
know day‐to‐day, so probably have the most accurate opinion of our … prescribing … And the pharmacists have
such a bulk of prescribing knowledge, more so than doctors.” F1B‐F.
3.5. Characteristics of a feedback
provider
3.5.1 “You're more open to it [feedback] if you're relaxed rather than taking it as a criticism, than getting more
defensive. And it's more a discussion about trying to improve than saying you've got this wrong.” F1B‐F.
3.5.2 “It was nice to be fairly reassured that I wasn't doing anything horrendously wrong … for the most part and
a couple of things that [the pharmacist] picked up I didn't know and are good to take forward.” F1B‐M.
3.6. Participant reflections on
filming
3.6.1 “Probably the thing I think I learnt the most was watching how many times I got interrupted whilst prescribing.
A drug chart is what 10 minutes I think I got interrupted 12 times during the process.” F1B‐M.
3.6.2 “You don't realise quite how many things there are that could distract you from your focus in the clinical
environment.” F1A‐M.
3.6.3 “Seeing yourself with patients is always interesting, things like how much eye contact you give them … we
always think we are giving them more eye contact than we are.” F1A‐M.
3.6.4 “It is interesting. I think there were a couple of times when I sort of heard what I wanted to hear … you
know, they [patients] start struggling and you kind of correct it for them and the danger is they're trying to say
something else entirely.” CT1A‐M.
3.7. Commitment to behaviour
change
3.7.1 “After the film I think I then thought perhaps next time I'm writing a drug chart I should try to make more of
an effort to go somewhere I'm not going to be distracted as opposed to sitting at the front desk where everyone
comes up to you and asks questions.” F1A‐F.
3.7.2 “I do now try and step away … unfortunately [X ward] don't have an office … so it's more a case of hiding in
the treatment room. But I'm more conscious of it.” F1B‐F.
3.7.3 “We get used to doing things in a hurry. Even when you're not in a hurry, sometimes do things more quickly
than you need to. You develop practices that you continue doing even when you don't need to do them.” F1A‐M.
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4.1 | Strengths and limitations
As with all projects, there are strengths and limitations. The strengths
are that: (i) the project builds on previous descriptive research15 to
make an evidence‐informed intervention in an authentic clinical set-
ting for a critical group of prescribers; (ii) the multiprofessional project
team (comprising pharmacists, a surgeon, a medical educator) worked
closely together to bridge the theory‐practice gap, which is a formida-
ble barrier to the implementation of research in practice; and (iii)
resource limitations of the clinical environment were carefully consid-
ered and taken into account by co‐designing an intervention that
would be feasible to implement in this setting. In this way, we have
successfully introduced a feasible low cost, acceptable intervention
to a busy clinical environment and made a tangible impact on
healthcare outcomes. The limitations of this project are that it involves
1 unit at a single UK hospital; feedback was predominantly given by a
single pharmacist; and there was no observation component to the
study to corroborate reported changes to prescribing practices that
might underpin the observed decrease in prescribing errors, although
the qualitative evidence supporting this interpretation was compelling.
There was also no denominator for the number of medication orders
written (so we have had to assume that stable or increasing patient
numbers means a stable or increasing number of medication orders)
and the relatively limited follow‐up time means that the persistence
of the feedback intervention effect is relatively underexplored. Fur-
thermore, since doctors‐in‐training in the UK typically rotate between
wards every 4 months, the intervention would ideally run at least 3
times per year, to maximise the impact, even though it is likely that
much of the learning will be transferable between settings.
4.2 | Recommendations for practice and future
research
During the project, increasing numbers of doctors‐in‐training were
reported to be utilising quieter spaces within the clinical environment
when completing drug charts, where possible. We recommend that
this practice is actively supported, encouraged by more senior clini-
cians and enabled by the design and configuration of clinical areas.
Other research suggests that feedback as a way of reducing prescrib-
ing errors should be part of a multifaceted approach.35 Our study
supports the idea that feedback outside of a supportive environment
(e.g. where feedback is not seen as supportive, or there is no support
provided for behaviour change) could be ineffective or even have
unintended consequences. It also became clear during the feedback
sessions that we simply do not praise the work of our doctors‐in‐
training enough and focus instead on lapses in judgement and errors.
We propose that educational interventions need to change to empha-
sise support and the development of doctors‐in‐training. This may
positively impact the workplace culture. Future research could include
larger implementations and evaluations of this feedback intervention
to explore the impact of involving a wider group of pharmacists in giv-
ing the feedback, verify the findings in other clinical settings and
explore the wider adoption and spread of this initiative; further devel-
opment work to optimise the feedback intervention,36 which might
include exploring the role of interprofessional learning; and exploring
the potential financial savings that might result from prescribing error
prevention. Other professions and undergraduate students might also
benefit from a similar intervention.
4.3 | Conclusions
Video‐stimulated reflection on prescribing events for doctors‐in‐
training, supported by tailored pharmacy feedback, significantly
reduced prescribing errors and was well received by participants.
Wider implementation of the initiative would be likely to lead to fur-
ther reductions in prescribing errors and support the development of
doctors‐in‐training.
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